Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36,687 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
First-in-human phase I/Ib study of QL1706 (PSB205), a bifunctional PD1/CTLA4 dual blocker, in patients with advanced solid tumors.
Zhao Y, Ma Y, Zang A, Cheng Y, Zhang Y, Wang X, Chen Z, Qu S, He J, Chen C, Jin C, Zhu D, Li Q, Liu X, Su W, Ba Y, Hao Y, Chen J, Zhang G, Qu S, Li Y, Feng W, Yang M, Liu B, Ouyang W, Liang J, Yu Z, Kang X, Xue S, Yang G, Yan W, Yang Y, Liu Z, Peng Y, Fanslow B, Huang X, Zhang L, Zhao H. Zhao Y, et al. Among authors: liu z, liu x, liu b. J Hematol Oncol. 2023 May 8;16(1):50. doi: 10.1186/s13045-023-01445-1. J Hematol Oncol. 2023. PMID: 37158938 Free PMC article. Clinical Trial.
[Chinese multicenter randomized trial of customized chemotherapy based on BRCA1 (breast cancer susceptibility gene 1)-RAP80 (receptor-associated protein 80) mRNA expression in advanced non-small cell lung cancer (NSCLC) patients].
Wei J, Qian XP, Zou ZY, Wang LF, Yu LX, You CW, Song Y, Lu HY, Hu WJ, Yan J, Xu XX, Chen XF, Li XY, Wu QF, Zhou Y, Zhang FL, Liu BR. Wei J, et al. Among authors: liu br. Zhonghua Zhong Liu Za Zhi. 2016 Nov 23;38(11):868-873. doi: 10.3760/cma.j.issn.0253-3766.2016.11.013. Zhonghua Zhong Liu Za Zhi. 2016. PMID: 27998448 Clinical Trial. Chinese.
Nanomodified Switch Induced Precise and Moderate Activation of CAR-T Cells for Solid Tumors.
Wang X, Meng F, Li X, Xue L, Chen A, Qiu Y, Zhang Z, Li L, Liu F, Li Y, Sun Z, Chu Y, Xu R, Yu L, Shao J, Tian M, Qian X, Liu Q, Liu B, Li R. Wang X, et al. Among authors: liu b, liu q, liu f. Adv Sci (Weinh). 2023 Apr;10(12):e2205044. doi: 10.1002/advs.202205044. Epub 2023 Feb 8. Adv Sci (Weinh). 2023. PMID: 36755195 Free PMC article.
Multicenter, single-arm, phase II study (CAP) of radiotherapy plus liposomal irinotecan followed by camrelizumab and anti-angiogenic treatment in advanced solid tumors.
Shen J, Yan J, Du J, Li X, Wei J, Liu Q, Yong H, Wang X, Chang X, Ding Z, Sun W, Liu C, Zhu S, Guo J, Li H, Liu Y, Zhang W, Liu Z, Li R, Liu B. Shen J, et al. Among authors: liu z, liu y, liu c, liu b, liu q. Front Immunol. 2023 Mar 28;14:1133689. doi: 10.3389/fimmu.2023.1133689. eCollection 2023. Front Immunol. 2023. PMID: 37056765 Free PMC article. Clinical Trial.
36,687 results
You have reached the last available page of results. Please see the User Guide for more information.